• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.失调的固有和适应性免疫反应可区分 COVID-19 的疾病严重程度。
J Infect Dis. 2021 Apr 23;223(8):1322-1333. doi: 10.1093/infdis/jiab065.
2
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.在细胞因子释放综合征背景下 SARS-CoV-2 感染的诊断。
Expert Rev Mol Diagn. 2020 Nov;20(11):1087-1097. doi: 10.1080/14737159.2020.1830760. Epub 2020 Oct 12.
3
The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.《2019 年冠状病毒病的纵向免疫反应:追寻细胞因子风暴》。
Arthritis Rheumatol. 2021 Jan;73(1):23-35. doi: 10.1002/art.41526. Epub 2020 Dec 1.
4
Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.严重的免疫抑制,而非细胞因子风暴,是 COVID-19 感染的特征。
JCI Insight. 2020 Sep 3;5(17):140329. doi: 10.1172/jci.insight.140329.
5
The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.SARS-CoV-2 与 COVID-19 免疫病理的免疫反应——当前观点。
Pulmonology. 2021 Sep-Oct;27(5):423-437. doi: 10.1016/j.pulmoe.2021.03.008. Epub 2021 Apr 9.
6
Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.COVID-19 中的细胞因子释放综合征:固有免疫、血管和血小板的致病因素在疾病严重程度和性别方面存在差异。
J Leukoc Biol. 2021 Jan;109(1):55-66. doi: 10.1002/JLB.3COVA0820-410RRR. Epub 2020 Sep 15.
7
SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.SARS-CoV-2 引起的细胞因子反应与其他严重感染患者中导致细胞因子风暴的呼吸道病毒不同。
Front Immunol. 2021 Mar 1;12:629193. doi: 10.3389/fimmu.2021.629193. eCollection 2021.
8
Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis.严重 COVID-19 患者纵向蛋白质组学分析中的细胞因子升高:与脓毒症的比较。
Front Immunol. 2022 Jan 12;12:798338. doi: 10.3389/fimmu.2021.798338. eCollection 2021.
9
Hyperinflammation and Immune Response Generation in COVID-19.COVID-19 中的过度炎症反应与免疫应答产生。
Neuroimmunomodulation. 2020;27(2):80-86. doi: 10.1159/000513198. Epub 2020 Dec 18.
10
Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.内皮功能障碍与失调的淋巴细胞反应和细胞因子网络共同导致了严重的 COVID-19。
Signal Transduct Target Ther. 2021 Dec 10;6(1):418. doi: 10.1038/s41392-021-00819-6.

引用本文的文献

1
Plasma proteomic profiles correlate with organ dysfunction in COVID-19 ARDS.血浆蛋白质组学图谱与新冠病毒感染相关急性呼吸窘迫综合征中的器官功能障碍相关。
Physiol Rep. 2025 Apr;13(7):e70300. doi: 10.14814/phy2.70300.
2
Delineating sex-specific circulating host response signatures associated with COVID-19 severity and mortality.描绘与COVID-19严重程度和死亡率相关的性别特异性循环宿主反应特征。
iScience. 2024 Oct 11;27(11):111150. doi: 10.1016/j.isci.2024.111150. eCollection 2024 Nov 15.
3
Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression.纵向转录变化揭示了自然杀伤细胞介导的细胞毒性通路中的基因,这些基因是 COVID-19 进展的关键因素。
Elife. 2024 Oct 29;13:RP94242. doi: 10.7554/eLife.94242.
4
Regulation of plasma soluble receptors of TNF and IL-1 in patients with COVID-19 differs from that observed in sepsis.新型冠状病毒肺炎患者血浆中肿瘤坏死因子(TNF)和白细胞介素-1(IL-1)可溶性受体的调节与脓毒症患者不同。
J Infect. 2024 Dec;89(6):106300. doi: 10.1016/j.jinf.2024.106300. Epub 2024 Sep 30.
5
ACE2-dependent and -independent SARS-CoV-2 entries dictate viral replication and inflammatory response during infection.ACE2 依赖性和非依赖性 SARS-CoV-2 进入决定了感染过程中的病毒复制和炎症反应。
Nat Cell Biol. 2024 Apr;26(4):628-644. doi: 10.1038/s41556-024-01388-w. Epub 2024 Mar 21.
6
Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patients.在苏丹和瑞典的系统性红斑狼疮(SLE)患者中,抗组蛋白和抗核小体抗体而非抗双链DNA抗体与干扰素诱导的生物标志物相关。
Rheumatology (Oxford). 2025 Mar 1;64(3):1170-1178. doi: 10.1093/rheumatology/keae134.
7
Sources of Variance in Human Tear Proteomic Samples: Statistical Evaluation, Quality Control, Normalization, and Biological Insight.人眼泪蛋白质组样品的变因来源:统计评估、品质控制、标准化和生物学见解。
Int J Mol Sci. 2024 Jan 26;25(3):1559. doi: 10.3390/ijms25031559.
8
Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2.检测 IFN-γ 和 IL-2 评估针对 SARS-CoV-2 的细胞免疫。
Sci Rep. 2024 Jan 11;14(1):1137. doi: 10.1038/s41598-024-51505-w.
9
Comprehensive proteomics and meta-analysis of COVID-19 host response.全面蛋白质组学和 COVID-19 宿主反应的荟萃分析。
Nat Commun. 2023 Sep 22;14(1):5921. doi: 10.1038/s41467-023-41159-z.
10
Prehospital physiological parameters related illness severity scores can accurately discriminate the severe/critical state in adult patients with COVID-19.院前生理参数相关疾病严重程度评分可准确区分 COVID-19 成年患者的严重/危急状态。
Ann Med. 2023;55(2):2239829. doi: 10.1080/07853890.2023.2239829.

失调的固有和适应性免疫反应可区分 COVID-19 的疾病严重程度。

Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.

机构信息

Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.

Department of Genetics, University Medical Center Groningen, Groningen, the Netherlands.

出版信息

J Infect Dis. 2021 Apr 23;223(8):1322-1333. doi: 10.1093/infdis/jiab065.

DOI:10.1093/infdis/jiab065
PMID:33524124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7928798/
Abstract

The clinical spectrum of COVID-19 varies and the differences in host response characterizing this variation have not been fully elucidated. COVID-19 disease severity correlates with an excessive proinflammatory immune response and profound lymphopenia. Inflammatory responses according to disease severity were explored by plasma cytokine measurements and proteomics analysis in 147 COVID-19 patients. Furthermore, peripheral blood mononuclear cell cytokine production assays and whole blood flow cytometry were performed. Results confirm a hyperinflammatory innate immune state, while highlighting hepatocyte growth factor and stem cell factor as potential biomarkers for disease severity. Clustering analysis revealed no specific inflammatory endotypes in COVID-19 patients. Functional assays revealed abrogated adaptive cytokine production (interferon-γ, interleukin-17, and interleukin-22) and prominent T-cell exhaustion in critically ill patients, whereas innate immune responses were intact or hyperresponsive. Collectively, this extensive analysis provides a comprehensive insight into the pathobiology of severe to critical COVID-19 and highlights potential biomarkers of disease severity.

摘要

新型冠状病毒疾病的临床谱变化多样,宿主反应的差异尚未完全阐明。新型冠状病毒疾病的严重程度与过度的促炎免疫反应和明显的淋巴细胞减少有关。通过对 147 例新型冠状病毒疾病患者的血浆细胞因子测量和蛋白质组学分析,研究了根据疾病严重程度的炎症反应。此外,还进行了外周血单核细胞细胞因子产生测定和全血流式细胞术。结果证实了一种过度的先天免疫状态,同时强调了肝细胞生长因子和干细胞因子作为疾病严重程度的潜在生物标志物。聚类分析显示,新型冠状病毒疾病患者没有特定的炎症表型。功能分析显示,危重症患者适应性细胞因子(干扰素-γ、白细胞介素-17 和白细胞介素-22)的产生受到抑制,T 细胞衰竭明显,而先天免疫反应完整或过度反应。总的来说,这项广泛的分析提供了对严重至危重新冠病毒疾病的病理生物学的全面了解,并强调了疾病严重程度的潜在生物标志物。